drugmaker

Roche says cancer setback to be cushioned by other drug development

Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday
Immunotherapy drug tiragolumab failed to slow progression of lung cancer in a second trial

By Reuters · 12 May 2022